查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571770

CBD 营养保健品市场规模、份额、趋势分析报告：按产品、按应用、按分销管道、按地区、细分市场预测，2024-2030 年

CBD Nutraceuticals Market Size, Share & Trends Analysis Report By Product (CBD Tinctures, Capsules & Softgels), By Application, By Distribution Channel (Retail Stores, Online), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

CBD 营养保健品市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，到 2030 年，全球 CBD 营养保健品市场规模预计将达到 231.7 亿美元，2024 年至 2030 年复合年增长率为 14.2%。

2018 年农业法案的出台，使大麻种植和大麻衍生产品在美国合法化，消费者对营养保健品中植物来源的偏好不断增加，以及对大麻二酚健康益处的认识正在推动市场增长，这些都是推动市场成长的因素。然而，替代产品的可用性阻碍了市场的成长。

CBD 酊剂细分市场在全球市场占据主导地位，2023 年占收益占有率的 41.9%。人们越来越接受大麻二酚用于健康和保健目的，再加上舌下给药时酊剂的高生物利用度，是这一巨大市场占有率背后的主要因素。另一方面，胶囊和软胶囊预计将成为预测期内成长最快的产品类型，因为它们适合旅行且方便在公共场所携带。然而，许多消费者不喜欢大麻二酚的原始味道和质地，转而使用胶囊和软胶囊。

从销售管道来看，2023年零售领域将主导市场，因为消费者更喜欢在零售店购买营养保健品。另一方面，由于人们对网路购物的偏好不断上升，因此预计线上销售管道在预测期内将以最快的复合年增长率扩张。此外，CBD 营养保健品领域的新进业者发现线上销售管道是比零售店更经济的选择。

CBD 营养保健品市场报告亮点

  • CBD 酊剂细分市场在全球市场占据主导地位，2023 年占收益占有率的 41.9%。为健康问题提供有效解决方案的能力，例如针对慢性疼痛、忧郁症和药物滥用障碍的治疗支持，缓解某些癌症症状的能力以及可用性正在推动这一领域的成长。
  • 2023年，食用和强化食品领域占据最大的销售份额。这一增长归因于 CBD食品配方的进步以及消费者对其健康益处的认识的提高。
  • 2023 年，零售店细分市场将主导全球市场。便利性、多种选择的可用性以及主要企业对提高品牌知名度的偏好都有助于零售店领域的成长。
  • 北美 CBD 营养保健品市场在全球产业中占据主导地位，2023 年收益占有率为 54.5%。该市场主要是由消费者意识的提高、CBD在各种应用中的日益采用以及美国和加拿大等国家的积极监管情况所推动的。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章 CBD 营养保健品市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • CBD 保健品市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 CBD 营养保健品市场：产品评估与趋势分析

  • 细分仪表板
  • CBD 营养保健品市场：2023 年和 2030 年产品变化分析
  • CBD酊剂
  • 胶囊和软胶囊
  • CBD 软糖
  • 其他的

第五章 CBD 营养保健品市场：使用量估计与趋势分析

  • 细分仪表板
  • CBD 营养保健品市场：2023 年和 2030 年应用变化分析
  • 食用食品和强化食品
  • 培训补充品
  • 健康
  • 其他的

第 6 章 CBD 保健品市场：通路估计与趋势分析

  • 细分仪表板
  • CBD 保健品市场：2023 年和 2030 年通路变化分析
  • 零售店
  • 在线的
  • 药局

第七章 CBD 保健品市场：区域估计与趋势分析

  • 2023 年及 2030 年 CBD 营养保健品市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Charlotte's Web, Inc.
    • Elixinol
    • Medical Marijuana, Inc.
    • CV Sciences, Inc.
    • Irwin Naturals
    • Diamond CBD.
    • Foria Wellness（Eden Partners LLC）
    • Medterra CBD
    • Green Roads
    • Isodiol International Inc
简介目录
Product Code: GVR-4-68038-156-6

CBD Nutraceuticals Market Growth & Trends:

The global CBD nutraceuticals market size is expected to reach USD 23.17 billion by 2030, registering a CAGR of 14.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Introduction of the 2018 Farm Bill that legalized hemp cultivation and hemp-derived products in U.S., rising consumer preference for plant-based ingredients in dietary supplements, and awareness regarding the health benefits of cannabidiol are some of the factors powering the market growth. However, the easy availability of alternative products is obstructing market growth.

CBD tinctures segment dominated the global market and accounted for a revenue share of 41.9% in 2023. Increasing acceptance of cannabidiol for health and wellness purposes coupled with high bioavailability of tinctures when administered sublingually are the major factors responsible for this large market share. On the other hand, capsules and soft gels are anticipated to be the fastest-growing product type over the forecast period, as they are travel-friendly and convenient to carry in public places. However, many consumers dislike the raw taste and texture of cannabidiol and so they are switching towards capsules and softgels.

Based on the distribution channel, retail store segment dominated the market in 2023, as consumers prefer retail stores for buying dietary supplements due to attractive pricing. On the other hand, the online sales channel is expected to expand at the fastest CAGR over the forecast period owing to the rise in the preference for online shopping. Furthermore, the new entrants in the CBD nutraceuticals space, find online sales channel a much economical alternative than a retail storefront.

CBD Nutraceuticals Market Report Highlights:

  • CBD tinctures segment dominated the global market and accounted for a revenue share of 41.9% in 2023. The ability of the product to provide effective solutions for health problems, such as assistance in treatments of chronic pain, depression, and substance use disorders, the capacity to alleviate specific cancer symptoms, and ease of availability, contribute to this segment's growth.
  • The edibles and fortified foods segment accounted for the largest revenue share in 2023. The growth is attributed to advancements in formulations of CBD foods and growing awareness among consumers about its health benefits.
  • Retail stores segment dominated the global market in 2023. Ease of accessibility, availability of multiple alternatives, and preference by key companies in order to accomplish enhanced brand visibility have contributed to the growth of retail store segment.
  • North America CBD nutraceuticals market dominated the global industry with a revenue share of 54.5% in 2023. This market is primarily driven by rising consumer awareness, increased adoption of CBD in various applications, and positive regulatory scenarios in countries such as the U.S. and Canada.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. CBD Nutraceuticals Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. CBD Nutraceuticals Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. CBD Nutraceuticals Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. CBD Nutraceuticals Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. CBD Tinctures
    • 4.3.1. CBD Tinctures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Capsules & Softgels
    • 4.4.1. Capsules & Softgels Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. CBD Gummies
    • 4.5.1. CBD Gummies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. CBD Nutraceuticals Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. CBD Nutraceuticals Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Edible and Fortified Foods
    • 5.3.1. Edible and Fortified Foods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Workout Supplements
    • 5.4.1. Workout Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Wellness
    • 5.5.1. Wellness Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. CBD Nutraceuticals Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. CBD Nutraceuticals Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Retail Stores
    • 6.3.1. Retail Stores Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Online
    • 6.4.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Pharmacies
    • 6.5.1. Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. CBD Nutraceuticals Market: Regional Estimates & Trend Analysis

  • 7.1. CBD Nutraceuticals Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Sweden
      • 7.3.8.1. Sweden CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Norway
      • 7.3.9.1. Norway CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Japan
      • 7.4.2.1. Japan CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. China
      • 7.4.3.1. China CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. Australia
      • 7.4.5.1. Australia CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. South Korea
      • 7.4.6.1. South Korea CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. South Africa
      • 7.6.2.1. South Africa CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. Saudi Arabia
      • 7.6.3.1. Saudi Arabia CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. UAE CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait CBD Nutraceuticals Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Charlotte's Web, Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Elixinol
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Medical Marijuana, Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. CV Sciences, Inc.
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Irwin Naturals
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Diamond CBD.
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Foria Wellness (Eden Partners LLC)
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Medterra CBD
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Green Roads
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Isodiol International Inc
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives